OVERVIEW

Chronic Lymphocytic Leukemia is organized by The Ohio State University Center for Continuing Medical Education (OSUCCME).

Course Dates: 11/08/2019 - 11/08/2022

Description:
Today on MedNet21, we're going to discuss Chronic Lymphocytic Leukemia.

Learners should expect to learn about the evaluation of lymphocytosis including findings that should prompt additional evaluation. They should be able to describe the diagnosis of chronic lymphocytic leukemia, small lymphocytic lymphoma, and monoclonal B-lymphocytosis. They should be able to explain the prognosis of these diseases in general terms and understand the implications for health maintenance.

During this second half of the lecture, viewers will learn about prognostic factors important in CLL, the rationale behind the watch and waiting for an approach to therapy, and indications for the first treatment. They will also learn about side effects that are common with the currently used targeted therapies for this disease.

Objective(s) :
As a result of this educational activity, webcast participants will be able to: RECOGNIZE that CLL is a chronic lymphoid malignancy that does not need treatment at diagnosis if asymptomatic and has a survival of many years; RECOGNIZE that CLL patients are at higher risk for second cancers or infection so it is important to all CLL patients with CLL should get all age-appropriate cancer screenings and vaccinations; UNDERSTAND indications for treatment in CLL and the rationale for the watch and wait for approach, and UNDERSTAND some serious side effects that can occur with oral targeted therapies in CLL. You’ll also learn about the following:
• Risks for CLL
• The current approach to the treatment of CLL
• Roles and limitations of automated WBC differentials
• Initial approach to lymphocytosis
• Emerging trends in first-line treatment of CLL
• Role of the age of the patient in therapeutic decision making
• Stem cell transplants

Note: You can watch OSU MedNet21 webcasts and get CME credit today. Viewers can watch the webcasts for free but will need to pay $25 for each post-test.